Optimizing Adherence to Antiretroviral Therapy

  • Author: Nancy Reynolds, PhD, RN, C-NP, FAAN (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/18 (What's New)

Summary

  • Patterns and level of adherence associated with risk for viral rebound and resistance vary by viral fitness and antiretroviral drug and regimen characteristics
  • DHHS, IAS-USA, and EACS recommend a number of coformulated, once-daily, and other simplified treatment options for initial ART[DHHS ART; IAS-USA ART; EACS ART]
  • Simplified treatment regimens are effective, favored by patients and providers, and associated with better adherence,[Blaschke 2008; Ortiz 2008; Riddler 2008; van Dulmen 2007; Nachega 2014] yet, it may be difficult for some patients to maintain high levels of adherence even to simplified regimens

Action required

Keywords: Adherence

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.